Page last updated: 2024-10-30

diisopropyl 1,3-dithiol-2-ylidenemalonate and Methemoglobinemia

diisopropyl 1,3-dithiol-2-ylidenemalonate has been researched along with Methemoglobinemia in 1 studies

diisopropyl 1,3-dithiol-2-ylidenemalonate: structure in first source

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahane, K1
Furuhama, K1
Inage, F1
Onodera, T1

Other Studies

1 other study available for diisopropyl 1,3-dithiol-2-ylidenemalonate and Methemoglobinemia

ArticleYear
Effects of malotilate on rat erythrocytes.
    Japanese journal of pharmacology, 1987, Volume: 45, Issue:1

    Topics: Anemia; Animals; Blood Viscosity; Cholesterol; Erythrocyte Deformability; Erythrocyte Membrane; Eryt

1987